The original article can be found on: Caribbean News Now By Caribbean News Now contributor
NEW YORK, USA — Drugmaker Johnson & Johnson has issued another recall of Motrin, this time from retailers, including those in Puerto Rico, Bahamas, Belize, St Lucia and Jamaica, bringing the number of recalls for this drug alone to six in the past two years.
J&J subsidiary McNeil Consumer Healthcare Division is voluntarily recalling certain lots of Motrin IB 24-count coated caplets, Motrin IB 24-count coated tablets and Motrin IB 24+6-count coated caplets from retailers. The products were distributed in the United States, Puerto Rico, Bahamas, Fiji, Belize, St Lucia and Jamaica.
This is not a consumer level recall, which means that consumers do not need to dispose of or return the product. There is no safety concern if consumers continue taking the product in accordance with its label; however, it is possible there may be a delay in experiencing relief. This action is not being undertaken on the basis of adverse events.
McNeil is recalling these products because testing of product samples showed that some caplets may not dissolve as quickly as intended when nearing their expiration date.
